跳至主要内容
临床试验/NCT02313090
NCT02313090已完成不适用

Study of Welltang- a Cell Phone-based Diabetes Management Application's Effect on Blood Glucose Control

First Affiliated Hospital of Zhejiang University0 个研究点目标入组 100 人开始时间: 2014年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
100
主要终点
HbA1c

研究概览

简要总结

The aim was to assess the impact of a cell phone-based diabetes management application (Welltang) on HbA1c, blood glucose, lipids, physical activity, weight, and blood pressure during 3 months. And hypoglycemic events, the satisfaction of the patients with Boyibang, their diabetes knowledge and self-care behaviors were also evaluated.

详细描述

At baseline, all patients completed the Diabetes Self- Care Behavior Questionnaire and a Diabetes Knowledge Survey. Health, medical and demographic history, height and weight, waist and hip circumferences, and blood pressure were recorded. HbA1c and low-density lipoprotein cholesterol (LDL-C) level were tested. All of these data were measured 3 months later at the conclusion of the study intervention.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All diabetes, aged more than 18 years old. No limit for HbA1c was defined

排除标准

  • patients have any severe complications such as end phase of diabetic nephropathy or proliferative retinopathy. patients who cannot use smart phone.

结局指标

主要结局

HbA1c

时间窗: 3 months

次要结局

  • low density lipoprotein cholesterol(3 months)
  • blood pressure(3 months)

研究者

发起方
First Affiliated Hospital of Zhejiang University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Zhou Weibin

Prime investigator

First Affiliated Hospital of Zhejiang University

相似试验